Related Experiment Videos
Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor
Olga Ujhelly1, Csilla Ozvegy, György Várady
1Institute of Hematology and Immunology, National Medical Center, Hungarian Academy of Sciences, Diószegi u. 64, H-1113 Budapest, Hungary.
Human Gene Therapy
|March 28, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Beyond animal models: using human pluripotent stem cell-derived stem and progenitor cells to predict cytotoxicity in normal tissues.
Pathology oncology research : POR·2026
Ligand-based pharmacophore modeling for the discovery of NaV1.7 inhibitors.
Journal of computer-aided molecular design·2026
Invalid Action Masking in Emergency Patient Scheduling.
Studies in health technology and informatics·2026
Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy.
Human gene therapy·2026
Advances in MOF-Based Transdermal Drug Delivery Systems: Mechanisms, Applications, and Future Prospects.
Topics in current chemistry (Cham)·2026
An evaluation of denecimig for bleeding prophylaxis in hemophilia A.
Expert opinion on biological therapy·2026
Thyroid Artery Embolization: A Review and Considerations for the Interventional Radiologist.
Seminars in interventional radiology·2026
Longitudinal Outcomes of Dolutegravir-Based Antiretroviral Therapy in a Large Nigerian Programmatic HIV-1 Cohort, 2017-2019.
Open forum infectious diseases·2026